Grant of Share Options

RNS Number : 4478U

Tristel PLC

21 December 2011

 



TRISTEL plc

Grant of Share Options

Tristel plc ("Tristel" or the "Company"), the manufacturer of infection control, contamination control and hygiene consumable products, announces today that Elizabeth Dixon, Finance Director, has been granted options over 10,000 ordinary shares of 1 pence each under the Tristel plc Enterprise Management Incentive Scheme 2005.  The share options are exercisable immediately, and for a period of ten years, at 53.75 pence per share. 

Following the grant of the options, Elizabeth Dixon now holds 10,000 shares and total options over 130,000 ordinary shares, of which 115,000 are exercisable.  

For further information:

Tristel plc	Tel: [phone]
Paul Swinney, Chief Executive Liz Dixon, Finance Director
Walbrook PR Ltd	Tel: [phone]
Fiona Henson	Mob: [phone] or [e-mail]
FinnCap
Geoff  Nash / Charlotte Stranner (Corporate Finance) Simon Starr (Corporate Broking)	Tel: [phone]

About Tristel plc

Tristel plc is an infection prevention and contamination control business headquartered in Newmarket, United Kingdom.  Its products are used to prevent hospital acquired infections, for hygiene in animal healthcare and by pharmaceutical and personal care manufacturers for contamination control.  Its leading brands are Tristel (infection prevention) and Crystel (contamination control).  The Group's products are considered to be amongst the highest performing biocides available to healthcare and industry.  Tristel's lead technology is a proprietary chlorine dioxide formulation used to disinfect instruments and surfaces and to control legionella and biofilm build up in water.

Tristel was admitted to the London Stock Exchange AIM market in June 2005.  Its stock exchange symbol is TSTL.

 

END

 

 

IOEFEUFIFFFSEDE